NasdaqGM - Nasdaq Real Time Price USD
89bio, Inc. (ETNB)
7.70
-0.09
(-1.16%)
At close: May 9 at 4:00:00 PM EDT
7.70
0.00
(0.00%)
After hours: May 9 at 4:05:11 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 8 | 9 |
| Avg. Estimate | -0.46 | -0.5 | -2.05 | -2.16 |
| Low Estimate | -0.52 | -0.62 | -2.36 | -2.87 |
| High Estimate | -0.4 | -0.4 | -1.74 | -1.25 |
| Year Ago EPS | -0.48 | -1.39 | -3.51 | -2.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.54 | -0.64 | -0.76 | -0.57 |
| EPS Actual | -0.48 | -1.39 | -1.02 | -0.49 |
| Difference | 0.06 | -0.75 | -0.26 | 0.08 |
| Surprise % | 11.71% | -116.50% | -34.32% | 13.29% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.46 | -0.5 | -2.05 | -2.16 |
| 7 Days Ago | -0.48 | -0.5 | -2.06 | -2.05 |
| 30 Days Ago | -0.48 | -0.5 | -2.01 | -1.98 |
| 60 Days Ago | -0.48 | -0.5 | -1.99 | -2.15 |
| 90 Days Ago | -0.63 | -0.65 | -2.6 | -2.78 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 1 |
| Up Last 30 Days | 1 | -- | 2 | -- |
| Down Last 7 Days | 1 | 1 | -- | 2 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ETNB | 3.40% | 64.02% | 41.54% | -5.06% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Initiated | Goldman Sachs: Neutral | 3/14/2025 |
| Initiated | Citigroup: Buy | 3/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
| Initiated | Wolfe Research: Outperform | 2/4/2025 |
| Maintains | UBS: Buy to Buy | 1/31/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/21/2025 |
Related Tickers
AKRO Akero Therapeutics, Inc.
39.85
-5.99%
OLMA Olema Pharmaceuticals, Inc.
4.6000
-1.50%
EWTX Edgewise Therapeutics, Inc.
14.58
-0.82%
DYN Dyne Therapeutics, Inc.
11.41
+1.02%
MDGL Madrigal Pharmaceuticals, Inc.
294.64
-1.65%
SLDB Solid Biosciences Inc.
2.7600
-0.36%
IDYA IDEAYA Biosciences, Inc.
17.42
-4.18%
CDTX Cidara Therapeutics, Inc.
18.63
-2.72%
REPL Replimune Group, Inc.
7.71
-0.77%
RYTM Rhythm Pharmaceuticals, Inc.
57.38
-5.50%